Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis

European Journal of Ophthalmology

Volumn 11, Issue 2, 2001, Pages 120-125

  Verin, Ph ^a   Allewaert, R ^a   Joyaux, J C ^a   Piozzi, E ^a   Koliopoulos, J ^a   Bloch Michel, E ^a  

^a Centre d'Ophtalmologie   (France)

Author keywords

Antihistamines; Mast cell stabilisers; Vernal keratoconjunctivitis

Indexed keywords

LEVOCABASTINE; LODOXAMIDE; LODOXAMIDE TROMETAMOL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPEREMIA; LACRIMATION; MAJOR CLINICAL STUDY; MALE; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERNAL CONJUNCTIVITIS;

EID: 0034941090     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210101100203     Document Type: Article

References (14)

1. Therapeutic review: Ocular allergy and mast cell stabilizers
2. Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapy
3. Treatment of common ocular disorders; a comparison of lodoxamide and NMGA
4. Randomized double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study
5. Comparison of topical 0.05% levocabastine and 01% lodoxamide in patients with allergic conjunctivitis
6. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma
7. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal conjunctivitis
8. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis
9. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis
10. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis
11. New directions in the therapy for ocular allergy
12. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis
13. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis
14. Classification of allergic conjunctivitis